{"id":4904,"date":"2012-11-14T10:45:00","date_gmt":"2012-11-14T07:45:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/"},"modified":"2026-01-19T11:09:51","modified_gmt":"2026-01-19T08:09:51","slug":"endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi","status":"publish","type":"post","link":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/","title":{"rendered":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130"},"content":{"rendered":"<div style=\"padding-bottom: 100px; margin: auto; width: 90%; display: flex; justify-content: center; flex-direction: column;\">\n<div align=\"center\">\n <b><span style=\"color: black\">END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130<\/span><\/b>\n<\/div>\n<div>\n <b>&nbsp;<\/b>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n Sa\u011fl\u0131k Uygulama Tebli\u011finde baz\u0131 ila\u00e7lar\u0131n kullan\u0131m\u0131nda endikasyon &nbsp;uyumu aranmaktad\u0131r. Bu ila\u00e7lar\u0131n endikasyonu haricinde kullan\u0131m\u0131nda ise Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen \u201cEndikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d istenmektedir. Ancak prospekt\u00fcs endikasyonunda yer almayan ve a\u015fa\u011f\u0131da ad\u0131 ge\u00e7en gruplarda belirtilen etken maddelerin e\u015fle\u015ftirilmi\u015f &nbsp;oldu\u011fu endikasyonlarda kullan\u0131m\u0131nda ise endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m raporu <b><u>aranmayacakt\u0131r.<\/u><\/b>\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n Bu listelerde yar almayan veya yer ald\u0131\u011f\u0131 halde farkl\u0131 endikasyonlarda kullan\u0131m\u0131nda endikasyon uyumu istenen ila\u00e7lar i\u00e7in ise mutlaka Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen &nbsp;&nbsp;\u201c Endikasyon d\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d nun fotokopisi re\u00e7eteye eklenecektir. Bu kullan\u0131m raporunun varl\u0131\u011f\u0131nda ise ilaca ait SUT h\u00fck\u00fcmlerine bak\u0131lmaks\u0131z\u0131n endikasyon d\u0131\u015f\u0131 kullan\u0131m raporunda belirtilen s\u00fcre ile kar\u015f\u0131lan\u0131r.\n<\/div>\n<div>\n &nbsp;\n<\/div>\n<div>\n &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ecz.Mehmet F\u0130TK\u0130\n<\/div>\n<div>\n &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sut Komisyonu Koordinat\u00f6r\u00fc\n<\/div>\n<div>\n<div style=\"text-align: justify\">\n  <u><strong><span style=\"color: #ff0000\">Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Ek Onay\u0131 Al\u0131nmadan Kullan\u0131labilecek &nbsp;Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7lar;<\/span><\/strong><\/u>\n <\/div>\n<div style=\"text-align: left\">\n  <b><span style=\"color: black\"><\/p>\n<div>\n     &nbsp;\n    <\/div>\n<div style=\"margin-left: 40px\">\n     <b><span style=\"color: black; font-size: 9pt\"><a href=\"http:\/\/www.iegm.gov.tr\/Folders\/file\/Endikasyon\/B%C3%96L%C3%9CM%20I%20HEMATOLOJ%C4%B0-ONKOLOJ%C4%B0%20%C4%B0LA%C3%87LARI.xls\"><span style=\"color: #993300\">B\u00f6l\u00fcm I: Onkoloji \u2013 Hematoloji \u0130la\u00e7lar\u0131<\/span><\/a><\/span><\/b>\n    <\/div>\n<div style=\"margin-left: 40px\">\n     <b><span style=\"color: black; font-size: 9pt\"><a href=\"http:\/\/www.iegm.gov.tr\/Folders\/file\/Endikasyon\/B%C3%96L%C3%9CM%20II%20G%C3%96Z%20%C4%B0LA%C3%87LARI.xls\"><span style=\"color: #993300\">B\u00f6l\u00fcm II: G\u00f6z \u0130la\u00e7lar\u0131<\/span><\/a><\/span><\/b>\n    <\/div>\n<div style=\"margin-left: 40px\">\n     <b><span style=\"color: black; font-size: 9pt\"><a href=\"http:\/\/www.iegm.gov.tr\/Folders\/file\/Endikasyon\/B%C3%96L%C3%9CM%20III%20PS%C4%B0K%C4%B0ATR%C4%B0%20%C4%B0LA%C3%87LARI.xls\"><span style=\"color: #993300\">B\u00f6l\u00fcm III: Psikiyatri Alan\u0131nda Kullan\u0131lan \u0130la\u00e7lar<\/span><\/a><\/span><\/b>&nbsp;\n    <\/div>\n<div>\n     <b><span style=\"color: black; font-size: 9pt\"><\/p>\n<div style=\"margin-left: 40px\">\n        <b><span style=\"color: black; font-size: 9pt\"><a href=\"http:\/\/www.iegm.gov.tr\/Folders\/file\/Endikasyon\/B%C3%96L%C3%9CM%20IV%20DERMATOLOJ%C4%B0%20%C4%B0LA%C3%87LARI.xls\"><span style=\"color: #993300\">B\u00f6l\u00fcm IV:Dermatoloji \u0130la\u00e7lar\u0131<\/span><\/a><\/span><\/b>\n       <\/div>\n<p> <\/span><\/b>\n    <\/div>\n<div style=\"margin-left: 40px\">\n     &nbsp;\n    <\/div>\n<div style=\"margin-left: 40px\">\n     <u><a href=\"http:\/\/www.iegm.gov.tr\/Default.aspx?sayfa=iegm_mevzuat&amp;lang=tr-TR&amp;thelawtype=6&amp;thelawId=142\">Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu ve Genel Duyuru i\u00e7in <em>TIKLAYINIZ.<\/em><\/a><\/u>\n    <\/div>\n<p> <\/span><\/b>\n <\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 &nbsp; &nbsp; Sa\u011fl\u0131k Uygulama Tebli\u011finde baz\u0131 ila\u00e7lar\u0131n kullan\u0131m\u0131nda endikasyon &nbsp;uyumu aranmaktad\u0131r. Bu ila\u00e7lar\u0131n endikasyonu haricinde kullan\u0131m\u0131nda ise Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen \u201cEndikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d istenmektedir. Ancak prospekt\u00fcs endikasyonunda yer almayan ve a\u015fa\u011f\u0131da ad\u0131 ge\u00e7en gruplarda belirtilen etken maddelerin e\u015fle\u015ftirilmi\u015f &nbsp;oldu\u011fu endikasyonlarda kullan\u0131m\u0131nda ise endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m raporu aranmayacakt\u0131r. &nbsp; Bu listelerde yar almayan veya yer ald\u0131\u011f\u0131 halde farkl\u0131 endikasyonlarda kullan\u0131m\u0131nda endikasyon uyumu istenen ila\u00e7lar i\u00e7in ise mutlaka Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen &nbsp;&nbsp;\u201c Endikasyon d\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d nun fotokopisi re\u00e7eteye eklenecektir. Bu kullan\u0131m raporunun varl\u0131\u011f\u0131nda ise ilaca ait SUT h\u00fck\u00fcmlerine bak\u0131lmaks\u0131z\u0131n endikasyon d\u0131\u015f\u0131 kullan\u0131m raporunda belirtilen s\u00fcre ile kar\u015f\u0131lan\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sut Komisyonu Koordinat\u00f6r\u00fc Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Ek Onay\u0131 Al\u0131nmadan Kullan\u0131labilecek &nbsp;Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7lar; &nbsp; B\u00f6l\u00fcm I: Onkoloji \u2013 Hematoloji \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm II: G\u00f6z \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm III: Psikiyatri Alan\u0131nda Kullan\u0131lan \u0130la\u00e7lar&nbsp; B\u00f6l\u00fcm IV:Dermatoloji \u0130la\u00e7lar\u0131 &nbsp; Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu ve Genel Duyuru i\u00e7in TIKLAYINIZ.<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 &nbsp; &nbsp; Sa\u011fl\u0131k Uygulama Tebli\u011finde baz\u0131 ila\u00e7lar\u0131n kullan\u0131m\u0131nda endikasyon &nbsp;uyumu aranmaktad\u0131r. Bu ila\u00e7lar\u0131n endikasyonu haricinde kullan\u0131m\u0131nda ise Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen \u201cEndikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d istenmektedir. Ancak prospekt\u00fcs endikasyonunda yer almayan ve a\u015fa\u011f\u0131da ad\u0131 ge\u00e7en gruplarda belirtilen etken maddelerin e\u015fle\u015ftirilmi\u015f &nbsp;oldu\u011fu endikasyonlarda kullan\u0131m\u0131nda ise endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m raporu aranmayacakt\u0131r. &nbsp; Bu listelerde yar almayan veya yer ald\u0131\u011f\u0131 halde farkl\u0131 endikasyonlarda kullan\u0131m\u0131nda endikasyon uyumu istenen ila\u00e7lar i\u00e7in ise mutlaka Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen &nbsp;&nbsp;\u201c Endikasyon d\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d nun fotokopisi re\u00e7eteye eklenecektir. Bu kullan\u0131m raporunun varl\u0131\u011f\u0131nda ise ilaca ait SUT h\u00fck\u00fcmlerine bak\u0131lmaks\u0131z\u0131n endikasyon d\u0131\u015f\u0131 kullan\u0131m raporunda belirtilen s\u00fcre ile kar\u015f\u0131lan\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sut Komisyonu Koordinat\u00f6r\u00fc Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Ek Onay\u0131 Al\u0131nmadan Kullan\u0131labilecek &nbsp;Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7lar; &nbsp; B\u00f6l\u00fcm I: Onkoloji \u2013 Hematoloji \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm II: G\u00f6z \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm III: Psikiyatri Alan\u0131nda Kullan\u0131lan \u0130la\u00e7lar&nbsp; B\u00f6l\u00fcm IV:Dermatoloji \u0130la\u00e7lar\u0131 &nbsp; Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu ve Genel Duyuru i\u00e7in TIKLAYINIZ.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-14T07:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:09:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130\",\"datePublished\":\"2012-11-14T07:45:00+00:00\",\"dateModified\":\"2026-01-19T08:09:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/\"},\"wordCount\":467,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/\",\"name\":\"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2012-11-14T07:45:00+00:00\",\"dateModified\":\"2026-01-19T08:09:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/11\\\/14\\\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/","og_locale":"tr_TR","og_type":"article","og_title":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 &nbsp; &nbsp; Sa\u011fl\u0131k Uygulama Tebli\u011finde baz\u0131 ila\u00e7lar\u0131n kullan\u0131m\u0131nda endikasyon &nbsp;uyumu aranmaktad\u0131r. Bu ila\u00e7lar\u0131n endikasyonu haricinde kullan\u0131m\u0131nda ise Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen \u201cEndikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d istenmektedir. Ancak prospekt\u00fcs endikasyonunda yer almayan ve a\u015fa\u011f\u0131da ad\u0131 ge\u00e7en gruplarda belirtilen etken maddelerin e\u015fle\u015ftirilmi\u015f &nbsp;oldu\u011fu endikasyonlarda kullan\u0131m\u0131nda ise endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m raporu aranmayacakt\u0131r. &nbsp; Bu listelerde yar almayan veya yer ald\u0131\u011f\u0131 halde farkl\u0131 endikasyonlarda kullan\u0131m\u0131nda endikasyon uyumu istenen ila\u00e7lar i\u00e7in ise mutlaka Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan hastaya verilen &nbsp;&nbsp;\u201c Endikasyon d\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu\u201d nun fotokopisi re\u00e7eteye eklenecektir. Bu kullan\u0131m raporunun varl\u0131\u011f\u0131nda ise ilaca ait SUT h\u00fck\u00fcmlerine bak\u0131lmaks\u0131z\u0131n endikasyon d\u0131\u015f\u0131 kullan\u0131m raporunda belirtilen s\u00fcre ile kar\u015f\u0131lan\u0131r. &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ecz.Mehmet F\u0130TK\u0130 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sut Komisyonu Koordinat\u00f6r\u00fc Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Ek Onay\u0131 Al\u0131nmadan Kullan\u0131labilecek &nbsp;Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7lar; &nbsp; B\u00f6l\u00fcm I: Onkoloji \u2013 Hematoloji \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm II: G\u00f6z \u0130la\u00e7lar\u0131 B\u00f6l\u00fcm III: Psikiyatri Alan\u0131nda Kullan\u0131lan \u0130la\u00e7lar&nbsp; B\u00f6l\u00fcm IV:Dermatoloji \u0130la\u00e7lar\u0131 &nbsp; Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Kullan\u0131m Raporu ve Genel Duyuru i\u00e7in TIKLAYINIZ.","og_url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2012-11-14T07:45:00+00:00","article_modified_time":"2026-01-19T08:09:51+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"2 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#article","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130","datePublished":"2012-11-14T07:45:00+00:00","dateModified":"2026-01-19T08:09:51+00:00","mainEntityOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/"},"wordCount":467,"commentCount":0,"publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/","name":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#primaryimage"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2012-11-14T07:45:00+00:00","dateModified":"2026-01-19T08:09:51+00:00","breadcrumb":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#primaryimage","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/11\/14\/endikasyon-disi-ilac-kullanimi-kilavuzu-yenilendi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/urfaeo.kolaysoft.com.tr\/"},{"@type":"ListItem","position":2,"name":"END\u0130KASYON DI\u015eI \u0130LA\u00c7 KULLANIMI KILAVUZU YEN\u0130LEND\u0130"}]},{"@type":"WebSite","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urfaeo.kolaysoft.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=4904"}],"version-history":[{"count":0,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=4904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=4904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=4904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}